Related Experiment Video
Updated: May 31, 2026

Visualizing the DNA Damage Response in Purkinje Cells Using Cerebellar Organotypic Cultures
Published on: December 27, 2024
TRAIL and guardian angel of genome integrity: ATM boards TRAIL blazer
Ammad Ahmad Farooqi1, Salman Waseem, Muhammad Sajjad Ashraf
1Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore, Pakistan. ammadahmad638@yahoo.com
Abstract:
Prostate cancer is a multifaceted progressive multistep disorder that arises because of accumulation of genetic and epigenetic abnormalities, which escort to the transformation of normal cells into malignant derivatives. Despite tremendous strides have been made in the understanding of prostate cancer biology, yet approaches towards cancer-targeted therapy still face confrontations in standardization. This review brings to attention, the regulators in complex genetic backgrounds to enlighten our understanding of transformation and metastasis in human systems. Recent evidence gives a clue that prostate cancer may be linked to deregulated DNA damage repair processes, as various combinations of targeted deletions in genes controlling cell-cycle checkpoints; apoptosis and DNA repair result in prostate cancer progression and aggressiveness. An insight of the orchestration between DNA damage-based molecular responses and TRAIL provides an understanding of the mechanisms that cause apoptosis and may provide rationale for the development of novel therapeutic strategies.
Insights
Prostate cancer involves genetic changes leading to cell transformation. Understanding DNA repair and cell death pathways may offer new therapeutic strategies for this complex disease.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate cancer is a complex, progressive disease driven by accumulated genetic and epigenetic alterations.
- Despite advances, standardizing targeted cancer therapies remains challenging.
- Understanding the molecular regulators of transformation and metastasis is crucial.
Purpose of the Study:
- To review regulators in complex genetic backgrounds influencing prostate cancer transformation and metastasis.
- To explore the link between deregulated DNA damage repair and prostate cancer progression.
- To provide insights into apoptosis mechanisms involving DNA damage responses and TRAIL for novel therapeutic development.
Main Methods:
- Literature review focusing on genetic and epigenetic abnormalities in prostate cancer.
- Analysis of recent evidence linking DNA damage repair processes to cancer progression.
- Examination of the interplay between DNA damage responses and TRAIL-mediated apoptosis.
Main Results:
- Prostate cancer progression and aggressiveness are associated with deletions in genes controlling cell-cycle checkpoints, apoptosis, and DNA repair.
- Deregulated DNA damage repair processes are implicated in the development of prostate cancer.
- The interaction between DNA damage responses and TRAIL offers a mechanistic understanding of apoptosis.
Conclusions:
- Insights into molecular regulators and DNA damage repair pathways are essential for understanding prostate cancer.
- Targeting DNA damage repair and apoptosis mechanisms, potentially involving TRAIL, may lead to novel therapeutic strategies.
- Further research into these complex genetic interactions can improve prostate cancer treatment.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Restarting Stalled Replication Forks
Nucleotide Excision Repair
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair

